BSE filing, NSE: LAXMIDENTL. Summary written from the filing by ALFA Finder's alert engine.
Laxmi Dental Ltd: key numbers
- Share price
- ₹181.39
- Market cap
- ₹998.2 Cr
- Revenue (annual)
- ₹277.9 Cr
- Net profit (annual)
- ₹28.98 Cr
- P/E (TTM)
- 32.3×Sector 52.0×
- Promoter holding
- 41.75%-0.05% QoQ
- FII holding
- 6.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Laxmi Dental Ltd
All →Laxmi Dental Board Meeting Date
Laxmi Dental scheduled a board meeting for November 3, 2026, to consider unaudited Q1 FY27 financial results. No financial figures are disclosed in this prior intimation.
Laxmi Dental Merger & Restructuring
Laxmi Dental Limited announced the incorporation of Leelaben Foundation, a Section 8 company, in which the company is a member, as previously approved by its board.
Laxmi Dental Business Update
Laxmi Dental's subsidiary received a tariff refund of ₹5.92 Crore from U.S. Customs following a regulatory change regarding excess tariffs collected.
- Value
- ₹5.92 Cr
- From
- U.S. Customs and Border Protection (CBP)
Laxmi Dental Legal & Regulatory
Laxmi Dental Limited's subsidiary, Laxmi Dental Lab USA, INC, received a tariff refund of approximately INR 5.92 Crore from U.S. Customs and Border Protection.
- Value
- ₹5.92 Cr
Laxmi Dental Other Announcement
The filing contains the quarterly shareholding pattern for Laxmi Dental Ltd as of September 30, 2026, submitted in compliance with SEBI Regulation 31(1)(b).
Laxmi Dental Other Announcement
Laxmi Dental submitted the Monitoring Agency Report for the quarter ended September 30, 2026, confirming utilization of IPO proceeds is in line with stated objects.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date